Engineering protein nanocages as carriers for biomedical applications
Source abstract
Abstract
Protein nanocages have been explored as potential carriers in biomedicine. Formed by the self-assembly of protein subunits, the caged structure has three surfaces that can be engineered: the interior, the exterior and the intersubunit. Therapeutic and diagnostic molecules have been loaded in the interior of nanocages, while their external surfaces have been engineered to enhance their biocompatibility and targeting abilities. Modifications of the intersubunit interactions have been shown to modulate the self-assembly profile with implications for tuning the molecular release. We review natural and synthetic protein nanocages that have been modified using chemical and genetic engineering techniques to impart non-natural functions that are responsive to the complex cellular microenvironment of malignant cells while delivering molecular cargos with improved efficiencies and minimal toxicity. Researchers have identified three components of self-assembled protein nanocages (PNCs)that can be engineered to improve delivery of molecular cargos. Biological systems such as virus capsids and the protein ferritin have cage-like structures and membrane-permeating capabilities that make them natural platform candidates for transporting molecules directly to cells. Sierin Lim and her team from Nanyang Technological University in Singapore survey progress in modifying PNCs interiors to improve drug loading, exteriors to enhance biocompatibility and display of ligands, and interactions between subunits to tune molecular release. Hybrid nanostructures that combine protein scaffolds with synthetic components, such as thermoresponsive polymers, are helping to impart additional functions to the PNCs. The authors foresee PNCs that combine multiple functionalities on a single platform and their development as agents in immunotherapy and immunoengineering as future directions for the field. Formed by the self-assembly of protein subunits, protein nanocages can be engineered at the interior, exterior, and inter-subunit locations. Each type of modification can be tuned for specific biological applications. Multiple-modifications can be imparted to these nanocages without compromising its self-assembling property, creating multi-functional protein nanocage platforms. Potential applications of the modified protein nanocages include targeted delivery in complex cellular environments for therapeutic and diagnostic agents as well as modulation of cellular responses.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bacteriophages and microbial interactions · Monoclonal and Polyclonal Antibodies Research · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (97)
Show source-provided references
1. Ferrer-Miralles, N., Rodríguez-Carmona, E., Corchero, J. L., García-Fruitós, E., Vázquez, E. & Villaverde, A. Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy. Crit. Rev. Biotechnol. 35, 209–221 (2013).10.3109/07388551.2013.833163 ↗
2. Yan, M., Du, J., Gu, Z., Liang, M., Hu, Y., Zhang, W., Priceman, S., Wu, L., Hong, Z., Zhou, H., Liu, Z., Segura, T., Tang, Y. & Lu, Y. A novel intracellular protein delivery platform based on single-protein nanocapsules. Nat. Nanotechnol. 5, 48–53 (2010).10.1038/nnano.2009.341 ↗
3. Lee, L. A. & Wang, Q. Adaptations of nanoscale viruses and other protein cages for medical applications. Nanomedicine 2, 137–149 (2006).10.1016/j.nano.2006.07.009 ↗
4. Flenniken, M. L., Uchida, M., Liepold, L. O., Kang, S., Young, M. J. & Douglas, T. A library of protein cage architectures as nanomaterials. Curr. Top. Microbiol. 327, 71–93 (2009).
5. Uchida, M., Klem, M. T., Allen, M., Suci, P., Flenniken, M., Gillitzer, E., Carpness, Z., Liepold, L. O., Young, M. & Douglas, T. Biological containers: protein cages as multifunctional nanoplatforms. Adv. Mater. 19, 1025–1042 (2007).10.1002/adma.200601168 ↗
6. Vazquez, E. & Villaverde, A. Engineering building blocks for self-assembling protein nanoparticles. Microb. Cell Fact 9, 101 (2010).10.1186/1475-2859-9-101 ↗
7. Schoonen, L. & van Hest, J. C. Functionalization of protein-based nanocages for drug delivery applications. Nanoscale 6, 7124–7141 (2014).10.1039/C4NR00915K ↗
8. Molino, N. M. & Wang, S. W. Caged protein nanoparticles for drug delivery. Curr. Opin. Biotechnol. 28, 75–82 (2014).10.1016/j.copbio.2013.12.007 ↗
9. Douglas, T., Allen, M., Young, M., Fahnestock, S. R. & Steinbüchel, A. Self-assembling protein cage systems and applications in nanotechnology (2005).10.1002/3527600035.bpol8015 ↗
10. Fontana, J., Dressick, W. J., Phelps, J., Johnson, J. E., Rendell, R. W., Sampson, T., Ratna, B. R. & Soto, C. M. Virus-templated plasmonic nanoclusters with icosahedral symmetry via directed self-assembly. Small 10, 3058–3063 (2014).10.1002/smll.201400470 ↗
11. Barnhill, H. N., Claudel-Gillet, S., Ziessel, R., Charbonniere, L. J. & Wang, Q. Prototype protein assembly as scaffold for time-resolved fluoroimmuno assays. J. Am. Chem. Soc. 129, 7799–7806 (2007).10.1021/ja069148u ↗
12. Fankuchen, I. & Ferritin:, V. X-ray diffraction data on ferritin and apoferritin. J. Biol. Chem. 150, 57–59 (1943).10.1016/S0021-9258(18)51250-3 ↗
13. Ford, G. C., Harrison, P. M., Rice, D. W., Smith, J. M., Treffry, A., White, J. L. & Yariv, J. Ferritin: design and formation of an iron-storage molecule. Philos. Trans. R. Soc. Lond. Ser. B 304, 551–565 (1984).10.1098/rstb.1984.0046 ↗
14. Lawson, D. M., Artymiuk, P. J., Yewdall, S. J., Smith, J. M., Livingstone, J. C., Treffry, A., Luzzago, A., Levi, S., Arosio, P., Cesareni, G., Thomas, C. D., Shaw, W. V. & Harrison, P. M. Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 349, 541–544 (1991).10.1038/349541a0 ↗
15. Johnson, E., Cascio, D., Sawaya, M. R., Gingery, M. & Schroder, I. Crystal structures of a tetrahedral open pore ferritin from the hyperthermophilic archaeon Archaeoglobus fulgidus. Structure 13, 637–648 (2005).10.1016/j.str.2005.01.019 ↗
16. Sana, B., Johnson, E., Sheah, K., Poh, C. L. & Lim, S. Iron-based ferritin nanocore as a contrast agent. Biointerphases 5, Fa48–Fa52 (2010).10.1116/1.3483216 ↗
17. Sana, B., Johnson, E. & Lim, S. The unique self-assembly/disassembly property of Archaeoglobus fulgidus ferritin and its implications on molecular release from the protein cage. Biochim. Biophys. Acta 1850, 2544–2551 (2015).10.1016/j.bbagen.2015.08.019 ↗
18. He, D. D. & Marles-Wright, J. Ferritin family proteins and their use in bionanotechnology. N. Biotechnol. 32, 651–657 (2015).10.1016/j.nbt.2014.12.006 ↗
19. Milne, J. L., Wu, X., Borgnia, M. J., Lengyel, J. S., Brooks, B. R., Shi, D., Perham, R. N. & Subramaniam, S. Molecular structure of a 9-MDa icosahedral pyruvate dehydrogenase subcomplex containing the E2 and E3 enzymes using cryoelectron microscopy. J. Biol. Chem. 281, 4364–4370 (2006).10.1074/jbc.M504363200 ↗
20. Dalmau, M., Lim, S., Chen, H. C., Ruiz, C. & Wang, S. W. Thermostability and molecular encapsulation within an engineered caged protein scaffold. Biotechnol. Bioeng. 101, 654–664 (2008).10.1002/bit.21988 ↗
21. Ren, D., Dalmau, M., Randall, A., Shindel, M. M., Baldi, P. & Wang, S. W. Biomimetic design of protein nanomaterials for hydrophobic molecular transport. Adv. Funct. Mater. 22, 3170–3180 (2012).10.1002/adfm.201200052 ↗
22. Domingo, G. J., Orru, S. & Perham, R. N. Multiple display of peptides and proteins on a macromolecular scaffold derived from a multienzyme complex. J. Mol. Biol. 305, 259–267 (2001).10.1006/jmbi.2000.4311 ↗
23. Kedersha, N. L. & Rome, L. H. Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA. J. Cell Biol. 103, 699–709 (1986).10.1083/jcb.103.3.699 ↗
24. Poderycki, M. J., Kickhoefer, V. A., Kaddis, C. S., Raval-Fernandes, S., Johansson, E., Zink, J. I., Loo, J. A. & Rome, L. H. The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry-US 45, 12184–12193 (2006).10.1021/bi0610552 ↗
25. Anderson, D. H., Kickhoefer, V. A., Sievers, S. A., Rome, L. H. & Eisenberg, D. Draft crystal structure of the vault shell at 9-A resolution. PLoS Biol. 5, e318 (2007).10.1371/journal.pbio.0050318 ↗
26. Han, M., Kickhoefer, V. A., Nemerow, G. R. & Rome, L. H. Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano 5, 6128–6137 (2011).10.1021/nn2014613 ↗
27. Kickhoefer, V. A., Han, M., Raval-Fernandes, S., Poderycki, M. J., Moniz, R. J., Vaccari, D., Silvestry, M., Stewart, P. L., Kelly, K. A. & Rome, L. H. Targeting vault nanoparticles to specific cell surface receptors. ACS Nano 3, 27–36 (2009).10.1021/nn800638x ↗
28. Matsumoto, N. M., Prabhakaran, P., Rome, L. H. & Maynard, H. D. Smart vaults: thermally-responsive protein nanocapsules. ACS Nano 7, 867–874 (2013).10.1021/nn3053457 ↗
29. Menon, B. B., Dou, Z., Heinhorst, S., Shively, J. M. & Cannon, G. C. Halothiobacillus neapolitanus carboxysomes sequester heterologous and chimeric RubisCO species. PLoS ONE 3, e3570 (2008).10.1371/journal.pone.0003570 ↗
30. Yeates, T. O., Crowley, C. S. & Tanaka, S. Bacterial microcompartment organelles: protein shell structure and evolution. Annu. Rev. Biophys. 39, 185–205 (2010).10.1146/annurev.biophys.093008.131418 ↗
31. Valdes-Stauber, N. & Scherer, S. Isolation and characterization of Linocin M18, a bacteriocin produced by Brevibacterium linens. Appl. Environ. Microbiol. 60, 3809–3814 (1994).10.1128/AEM.60.10.3809-3814.1994 ↗
32. Yeates, T. O. & Padilla, J. E. Designing supramolecular protein assemblies. Curr. Opin. Struct. Biol. 12, 464–470 (2002).10.1016/S0959-440X(02)00350-0 ↗
33. Padilla, J. E., Colovos, C. & Yeates, T. O. Nanohedra: using symmetry to design self-assembling protein cages, layers, crystals, and filaments. Proc. Natl. Acad. Sci. U.S.A. 98 (5), 2217–21 (2001).10.1073/pnas.041614998 ↗
34. Lai, Y. T., King, N. P. & Yeates, T. O Principles for designing ordered protein assemblies. Trends Cell Biol. 22, 653–61 (2012).10.1016/j.tcb.2012.08.004 ↗
35. Lai, Y. T., Tsai, K. L., Sawaya, M. R., Asturias, F. J. & Yeates, T. O Structure and flexibility of nanoscale protein cages designed by symmetric self-assembly. J. Am. Chem. Soc. 135, 7738–7743 (2013).10.1021/ja402277f ↗
36. Bale, J. B., Gonen, S., Liu, Y., Sheffler, W., Ellis, D., Thomas, C., Cascio, D., Yeates, T. O., Gonen, T., King, N. P. & Baker, D. Accurate design of megadalton-scale two-component icosahedral protein complexes. Science 353 (6297), 389–394 (2016).10.1126/science.aaf8818 ↗
37. Gradišar, H., Božič, S., Doles, T., Vengust, D., Hafner-Bratkovič, I., Mertelj, A., Webb, B., Šali, A., Klavžar, S. & Jerala, R. Design of a single-chain polypeptide tetrahedron assembled from coiled-coil segments. Nat. Chem. Biol. 9, 362–366 (2013).10.1038/nchembio.1248 ↗
38. Raja, K. S., Wang, Q., Gonzalez, M. J., Manchester, M., Johnson, J. E. & Finn, M. G. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus. Biomacromolecules 4, 472–476 (2003).10.1021/bm025740+ ↗
39. Lucon, J., Qazi, S., Uchida, M., Bedwel, G. J., LaFrance, B., Prevelige, P. E. Jr & Douglas, T. Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. Nat. Chem. 4, 781–788 (2012).10.1038/nchem.1442 ↗
40. Maham, A., Tang, Z., Wu, H., Wang, J. & Lin, Y. Protein-based nanomedicine platforms for drug delivery. Small 5, 1706–1721 (2009).10.1002/smll.200801602 ↗
41. Kohane, D. S. & Langer, R. Biocompatibility and drug delivery systems. Chem. Sci. 1, 441–446 (2010).10.1039/C0SC00203H ↗
42. Naahidi, S., Jafari, M., Edalat, F., Raymond, K., Khademhosseini, A. & Chen, P. Biocompatibility of engineered nanoparticles for drug delivery. J. Control. Rel. 166, 182–194 (2013).10.1016/j.jconrel.2012.12.013 ↗
43. Peng, T. & Lim, S. Trimer-based design of pH-responsive protein cage results in soluble disassembled structures. Biomacromolecules 12, 3131–3138 (2011).10.1021/bm2005438 ↗
44. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6, 688–701 (2006).10.1038/nrc1958 ↗
45. Ashley, C. E., Carnes, E. C., Phillips, G. K., Durfee, P. N., Buley, M. D., Lino, C. A., Padilla, D. P., Phillips, B., Carter, M. B., Willman, C. L., Brinker, C. J., Caldeira, Jdo, C., Chackerian, B., Wharton, W. & Peabody, D. S. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. ACS Nano 5, 5729–5745 (2011).10.1021/nn201397z ↗
46. Volk, A. L., Rivera, A. A., Kanerva, A., Bauerschmitz, G., Dmitriev, I., Nettelbeck, D. M. & Curiel, D. T. Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5/3 chimerism. Cancer Biol. Ther. 2, 511–515 (2003).10.4161/cbt.2.5.440 ↗
47. Stevenson, S. C., Rollence, M., White, B., Weaver, L. & McClelland, A. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain. J. Virol. 69, 2850–2857 (1995).10.1128/JVI.69.5.2850-2857.1995 ↗
48. Gillitzer, E., Willits, D., Young, M. & Douglas, T. Chemical modification of a viral cage for multivalent presentation. Chem. Commun. 2390–2391 (2002).10.1039/b207853h ↗
49. Smith, M. L., Fitzmaurice, W. P., Turpen, T. H. & Palmer, K. E. Display of peptides on the surface of tobacco mosaic virus particles. Curr. Top. Microbiol. Immunol. 332, 13–31 (2009).
50. Schlick, T. L., Ding, Z., Kovacs, E. W. & Francis, M. B. Dual-surface modification of the tobacco mosaic virus. J. Am. Chem. Soc. 127, 3718–3723 (2005).10.1021/ja046239n ↗
51. Kovacs, E. W., Hooker, J. M., Romanini, D. W., Holder, P. G., Berry, K. E. & Francis, M. B. Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. Bioconjugate Chem. 18, 1140–1147 (2007).10.1021/bc070006e ↗
52. Dedeo, M. T., Finley, D. T. & Francis, M. B. Viral capsids as self-assembling templates for new materials. Prog. Mol. Biol. Transl. 103, 353–392 (2011).10.1016/B978-0-12-415906-8.00002-9 ↗
53. Chen, L., Zurita, A. J., Ardelt, P. U., Giordano, R. J., Arap, W. & Pasqualini, R. Design and validation of a bifunctional ligand display system for receptor targeting. Chem. Biol. 11, 1081–1091 (2004).10.1016/j.chembiol.2004.05.019 ↗
54. Shin, H. I., Chae, K. H. & Cho, T. J. Modification of Turnip yellow mosaic virus coat protein and its effect on virion assembly. BMB Rep. 46, 495–500 (2013).10.5483/BMBRep.2013.46.10.046 ↗
55. Zeng, Q., Saha, S., Lee, L. A., Barnhill, H., Oxsher, J., Dreher, T. & Wang, Q. Chemoselective modification of turnip yellow mosaic virus by Cu(I) catalyzed azide-alkyne 1,3-dipolar cycloaddition reaction and its application in cell binding. Bioconjugate Chem. 22, 58–66 (2011).10.1021/bc100351n ↗
56. Flenniken, M. L., Willits, D. A., Harmsen, A. L., Liepold, L. O., Harmsen, A. G., Young, M. J. & Douglas, T. Melanoma and lymphocyte cell-specific targeting incorporated into a heat shock protein cage architecture. Chem. Biol. 13, 161–170 (2006).10.1016/j.chembiol.2005.11.007 ↗
57. Flenniken, M. L., Willits, D. A., Brumfield, S., Young, M. J. & Douglas, T. The small heat shock protein cage from Methanococcus jannaschii is a versatile nanoscale platform for genetic and chemical modification. Nano Lett. 3, 1573–1576 (2003).10.1021/nl034786l ↗
58. Pan, Y., Zhang, Y., Jia, T., Zhang, K., Li, J. & Wang, L. Development of a microRNA delivery system based on bacteriophage MS2 virus-like particles. FEBS J. 279, 1198–1208 (2012).10.1111/j.1742-4658.2012.08512.x ↗
59. Zhao, Q., Chen, W., Chen, Y., Zhang, L., Zhang, J. & Zhang, Z. Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. Bioconjugate Chem. 22, 346–352 (2011).10.1021/bc1002532 ↗
60. Ma, Y., Nolte, R. J. & Cornelissen, J. J. Virus-based nanocarriers for drug delivery. Adv. Drug Deliv. Rev. 64, 811–825 (2012).10.1016/j.addr.2012.01.005 ↗
61. Schmidt, U., Rudolph, R. & Bohm, G. Binding of external ligands onto an engineered virus capsid. Protein Eng. 14, 769–774 (2001).10.1093/protein/14.10.769 ↗
62. Seebeck, F. P., Woycechowsky, K. J., Zhuang, W., Rabe, J. P. & Hilvert, D. A simple tagging system for protein encapsulation. J. Am. Chem. Soc. 128, 4516–4517 (2006).10.1021/ja058363s ↗
63. Fan, C. G., Cheng, S., Liu, Y., Escobar, C. M., Crowley, C. S., Jefferson, R. E., Yeates, T. O. & Bobik, T. A. Short N-terminal sequences package proteins into bacterial microcompartments. Proc. Natl. Acad. Sci. USA 107, 7509–7514 (2010).10.1073/pnas.0913199107 ↗
64. Uchida, M., Kang, S., Reichhardt, C., Harlen, K. & Douglas, T. The ferritin superfamily: Supramolecular templates for materials synthesis. Biochim. Biophys. Acta 1800, 834–845 (2010).10.1016/j.bbagen.2009.12.005 ↗
65. Lin, X., Xie, J., Niu, G., Zhang, F., Gao, H., Yang, M., Quan, Q., Aronova, M. A., Zhang, G., Lee, S., Leapman, R. & Chen, X. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett. 11, 814–819 (2011).10.1021/nl104141g ↗
66. Goldsmith, L. E., Pupols, M., Kickhoefer, V. A., Rome, L. H. & Monbouquette, H. G. Utilization of a protein ‘shuttle’ to load vault nanocapsules with gold probes and proteins. ACS Nano 3, 3175–3183 (2009).10.1021/nn900555d ↗
67. Kickhoefer, V. A., Garcia, Y., Mikyas, Y., Johansson, E., Zhou, J. C., Raval-Fernandes, S., Minoofar, P., Zink, J. I., Dunn, B., Stewart, P. L. & Rome, L. H Engineering of vault nanocapsules with enzymatic and fluorescent properties. Proc. Natl. Acad. Sci. USA 102, 4348–4352 (2005).10.1073/pnas.0500929102 ↗
68. Ren, D., Kratz, F. & Wang, S. W. Protein nanocapsules containing doxorubicin as a pH-responsive delivery system. Small 7, 1051–1060 (2011).10.1002/smll.201002242 ↗
69. Wu, W., Xing, L., Zhou, B. H. & Lin, Z. L. Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb. Cell Fact 10 (2011).10.1186/1475-2859-10-9 ↗
70. Bode, S. A., Minten, I. J., Nolte, R. J. & Cornelissen, J. J. Reactions inside nanoscale protein cages. Nanoscale 3, 2376–2389 (2011).10.1039/c0nr01013h ↗
71. Abedin, M. J., Liepold, L., Suci, P., Young, M. & Douglas, T. Synthesis of a cross-linked branched polymer network in the interior of a protein cage. J. Am. Chem. Soc. 131, 4346–4354 (2009).10.1021/ja8079862 ↗
72. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R. & Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007).10.1038/nnano.2007.387 ↗
73. Wu, Y., Ng, D. Y., Kuan, S. L. & Weil, T. Protein–polymer therapeutics: a macromolecular perspective. Biomater. Sci. 3, 214–230 (2015).10.1039/C4BM00270A ↗
74. Domingo, G. J., Caivano, A., Sartorius, R., Barba, P., Bäckström, M., Piatier-Tonneau, D., Guardiola, J., De Berardinis, P. & Perham, R. N. Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex. Vaccine 21, 1502–1509 (2003).10.1016/S0264-410X(02)00664-3 ↗
75. Kang, S., Suci, P. A., Broomell, C. C., Iwahori, K., Kobayashi, M., Yamashita, I., Young, M. & Douglas, T. Janus-like protein cages. Spatially controlled dual-functional surface modifications of protein cages. Nano Lett. 9, 2360–2366 (2009).10.1021/nl9009028 ↗
76. Suci, P. A., Kang, S., Young, M. & Douglas, T. A streptavidin-protein cage Janus particle for polarized targeting and modular functionalization. J. Am. Chem. Soc. 131, 9164–9165 (2009).10.1021/ja9035187 ↗
77. Tang, J., Johnson, J. M., Dryden, K. A., Young, M. J., Zlotnick, A. & Johnson, J. E. The role of subunit hinges and molecular ‘switches’ in the control of viral capsid polymorphism. J. Struct. Biol. 154, 59–67 (2006).10.1016/j.jsb.2005.10.013 ↗
78. Zhang, Y., Fu, J., Chee, S. Y., Ang, E. X. W. & Orner, B. P. Rational disruption of the oligomerization of the mini-ferritin E. coli DPS through protein-protein interface mutation. Protein Sci. 20, 1907–1917 (2011).10.1002/pro.731 ↗
79. Dalmau, M., Lim, S. & Wang, S. W. Design of a pH-dependent molecular switch in a caged protein platform. Nano Lett. 9, 160–166 (2009).10.1021/nl8027069 ↗
80. MacDonald, J. I., Munch, H. K., Moore, T. & Francis, M. B. One-step site-specific modification of native proteins with 2-pyridinecarboxyaldehydes. Nat. Chem. Biol. 11, 326–331 (2015).10.1038/nchembio.1792 ↗
81. Flenniken, M. L., Liepold, L. O., Crowley, B. E., Willits, D. A., Young, M. J. & Douglas, T. Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. Chem. Commun. 447–449 (2005).10.1039/b413435d ↗
82. Yang, Z., Wang, X., Diao, H., Zhang, J., Li, H., Sun, H. & Guo, Z. Encapsulation of platinum anticancer drugs by apoferritin. Chem. Commun. 3453–3455 (2007).10.1039/b705326f ↗
83. Fang, C. Y., Lin, P. Y., Ou, W. C., Chen, P. L., Shen, C. H., Chang, D. & Wang, M. Analysis of the size of DNA packaged by the human JC virus-like particle. J. Virol. Methods 182, 87–92 (2012).10.1016/j.jviromet.2012.03.017 ↗
84. Choi, K. M., Kim, K., Kwon, I. C., Kim, I. S. & Ahn, H. J. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo. Mol. Pharmaceut. 10, 18–25 (2013).10.1021/mp300211a ↗
85. Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H. & Chatterjee, D. K. Protein delivery using engineered virus-like particles. Proc. Natl. Acad. Sci. USA 108, 16998–17003 (2011).10.1073/pnas.1101874108 ↗
86. Lee, H., Song, J. J., Kim, E., Yun, C-O., Choi, J., Lee, B., Kim, J., Chang, J. W. & Kim, J.-H. Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor. Gene Therapy 8, 268–273 (2001).10.1038/sj.gt.3301390 ↗
87. Lakshmanan, A. et al. Molecular Engineering of Acoustic Protein Nanostructures. ACS Nano 10, 7314–7322 (2016).10.1021/acsnano.6b03364 ↗
88. Hooker, J. M., O'Neil, J. P., Romanini, D. W., Taylor, S. E. & Francis, M. B. Genome-free viral capsids as carriers for positron emission tomography radiolabels. Mol. Imag. Biol. 10, 182–191 (2008).10.1007/s11307-008-0136-5 ↗
89. Harrison, P. M. & Arosio, P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275, 161–203 (1996).10.1016/0005-2728(96)00022-9 ↗
90. Champion, C. I., Kickhoefer, V. A., Liu, G., Moniz, R. J., Freed, A. S., Bergmann, L. L., Vaccari, D., Raval-Fernandes, S., Chan, A. M., Rome, L. H. & Kelly, K. A. A vault nanoparticle vaccine induces protective mucosal immunity. PLoS ONE 4, e5409 (2009).10.1371/journal.pone.0005409 ↗
91. Kanekiyo, M., Wei, C. J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R., Rao, S. S., Kong, W. P., Wang, L. & Nabel, G. J. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102–106 (2013).10.1038/nature12202 ↗
92. Plummer, E. M. & Manchester, M. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design. Wiley Interdiscip. Rev. 3, 174–196 (2011).
93. Farris, C. M. & Morrison, R. P. Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model. Infect. Immun. 79, 986–996 (2011).10.1128/IAI.00881-10 ↗
94. Akahata, W., Yang, Z. Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W. P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S. & Nabel, G. J. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med. 16, 334–338 (2010).10.1038/nm.2105 ↗
95. Quan, F. S., Kim, Y., Lee, S., Yi, H., Kang, S. M., Bozja, J., Moore, M. L. & Compans, R. W. Virus like particle vaccine induces protection against respiratory syncytial virus infection in mice. J. Infect. Dis. 204, 987–995 (2011).10.1093/infdis/jir474 ↗
96. Murawski, M. R., McGinnes, L. W., Finberg., R. W., Kurt-Jones, E. A., Massare, M. J., Smith, G., Heaton, P. M., Fraire, A. E. & Morrison, T. G. Newcastle disease virus-like particles containing respiratory syncytial virus g protein induced protection in BALB/c mice, with no evidence of immunopathology. J. Virol. 84, 1110–1123 (2010).10.1128/JVI.01709-09 ↗
97. Zhu, Y., Jiang, J., Said-Sadier, N., Boxx, G., Champion, C., Tetlow, A., Kickhoefer, V. A., Rome, L. H., Ojcius, D. M. & Kelly, K. A. Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope. Vaccine 33, 298–306 (2015).10.1016/j.vaccine.2014.11.028 ↗